News

A study of 3,438 toddlers found slightly lower emotional and behavioral problems among children assessed during the COVID-19 pandemic.

Tezepelumab received FDA approval for CRSwNP in patients 12 years and older, supported by strong phase 3 data.

At CNS 2025, Kathryn Xixis, MD, highlighted the growing adoption of EPAs and outcomes-based learning in pediatric neurology.

Indication expansions include hidradenitis suppurativa for patients 12 years and up, as well as for patients with uveitis aged 2 years and older.

In our second interview with Peace Madueme, MD, he explains the types of conditions that frequently appear on ECGs, which are aiding routine sports physicals in youth athletes in Florida.

A pediatrician warns of the resurgence of vaccine-preventable diseases, urging awareness of their devastating impacts on children's health.

IDWeek 2025 heads to Atlanta October 19–22 with cutting-edge sessions on AMR, AI, vaccines, HIV, pediatrics, and global health challenges.

IDSA’s new GAS pharyngitis guidance emphasizes selective testing using clinical scoring to reduce overtreatment and antibiotic misuse.

At the 2025 CNS Annual Meeting, Craig Press, MD, PhD, discussed challenges in achieving equitable access to diagnostics and expertise in pediatric neurocritical care.

Integrating health care and behavioral science transforms experiences for neurodivergent children, reducing anxiety and fostering confidence during medical procedures.

In a recent trial, 11 of 12 children treated with DB-OTO demonstrated meaningful hearing gains.

FDA accepts MannKind’s sBLA for Afrezza in children and adolescents with diabetes.

This issue has a number of outstanding must-read articles related to pediatric vaccines.

Explore effective techniques for gathering psychosocial histories from adolescents using the HEADS FIRST Checklist to enhance mental health interventions.

Can you guess the diagnosis?

Discover the benefits of shea butter-based emollients in diapers, offering effective protection against diaper rash and skin irritation for babies.

Tapering adalimumab in inflammatory arthritis reduces flare rates and enhances recovery compared to abrupt discontinuation.

Joseph Vithayathil, MD, discusses being awarded the Elterman Research Grant at the 2025 CNS Annual Meeting in Charlotte, North Carolina.

Explore the connection between recurrent lymphadenitis and tonsillectomy in children, highlighting diagnosis, treatment, and potential long-term complications.

Physicians embrace AI scribe technology, reporting enhanced efficiency, reduced burnout, and improved documentation quality in clinical workflows.

The BeeLine trial is a placebo-controlled study designed to evaluate radiprodil’s impact on both seizure frequency and non-seizure symptoms associated with GRIN-NDD.

Training tools and EHR prompts boosted pediatricians’ adherence to early peanut introduction guidelines in a new trial.

Peace Madueme, MD, explains how Florida’s pre-sports cardiac evaluations—and upcoming ECG mandate—strengthen youth safety in athletics.

A pair of roflumilast clinical trial investigators react to the FDA approval of the 0.05% formulation to treat atopic dermatitis in children aged 2 to 5 years.

Try to diagnose this patient with 3 days of right-sided neck swelling.

Lori Handy, MD, MSCE, addresses rising vaccine inquiries, emphasizing informed decisions that balance risks and benefits for children's health and safety.

The once-daily, steroid-free cream can be used anywhere on the body for treatment and for any duration, according to Arcutis.

Combination vaccines enhance childhood immunization by reducing the number of shots, improving adherence, and potentially increasing overall vaccination rates.